ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
150 hedge funds and large institutions have $1.09B invested in Acorda Therapeutics in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $1.26B → $1.09B (-$170M)
65% less call options, than puts
Call options by funds: $4.38M | Put options by funds: $12.7M
Holders
150
Holding in Top 10
1
Calls
$4.38M
Puts
$12.7M
Top Buyers
| 1 | +$9.54M | |
| 2 | +$9.08M | |
| 3 | +$8.74M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.41M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.74M |
Top Sellers
| 1 | -$24.9M | |
| 2 | -$21.3M | |
| 3 | -$12.9M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$11.4M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11.1M |